Department of Human and General Physiology, University of Bologna, Piazza di Porta San Donato 2, 40126 Bologna.
Department of Human and General Physiology, University of Bologna, Piazza di Porta San Donato 2, 40126 Bologna; Center for Applied Biomedical Research, S. Orsola-Malpighi University Hospital, 40138 Bologna, Italy.
J Biol Chem. 2010 Mar 26;285(13):10098-10109. doi: 10.1074/jbc.M109.043711. Epub 2010 Jan 18.
The endocannabinoid system is involved in the regulation of many physiological effects in the central and peripheral nervous system. Recent findings have demonstrated the presence of a functional endocannabinoid system within neuronal progenitors located in the hippocampus and ventricular/subventricular zone that participates in the regulation of cell proliferation. It is presently unknown whether the endocannabinoid system exerts a widespread effect on neuronal precursors from different neurogenic regions, and very little is known about the signaling by which it regulates neuronal precursor proliferation. Herein, we demonstrate the presence of cannabinoid CB(1) receptors in granule cell precursors (GCPs) during early cerebellar development. Activation of CB(1) receptors by HU-210 promoted GCP proliferation in vitro, an effect that was prevented by a selective CB(1) antagonist. Accordingly, in vivo experiments showed that GCP proliferation was increased by chronic HU-210 treatment and that in CB(1)-deficient mice cell proliferation was significantly lower than in wild-type littermates, indicating that the endocannabinoid system is physiologically involved in regulation of GCP proliferation. The pro-proliferative effect of cannabinoids in GCPs was mediated through the CB(1)/AKT/glycogen synthase kinase-3beta/beta-catenin pathway. Involvement of this pathway was also observed in cultures of neuronal precursors from the subventricular zone, suggesting that this pathway may be a general mechanism by which endocannabinoids regulate proliferation of neuronal precursors. These observations suggest that endocannabinoids constitute a new family of lipid signaling cues that may exert a widespread effect on neuronal precursor proliferation during brain development.
内源性大麻素系统参与中枢和外周神经系统中许多生理效应的调节。最近的研究结果表明,在海马和脑室/室下区的神经元祖细胞中存在功能性内源性大麻素系统,该系统参与细胞增殖的调节。目前尚不清楚内源性大麻素系统是否对来自不同神经发生区域的神经元前体细胞产生广泛影响,而且关于其调节神经元前体细胞增殖的信号转导知之甚少。在此,我们在早期小脑发育过程中证明了大麻素 CB(1)受体存在于颗粒细胞前体细胞 (GCPs) 中。HU-210 激活 CB(1)受体可促进体外 GCP 增殖,而选择性 CB(1)拮抗剂可阻止该作用。因此,体内实验表明,慢性 HU-210 处理可增加 GCP 增殖,而在 CB(1)缺陷型小鼠中,细胞增殖明显低于野生型同窝仔鼠,表明内源性大麻素系统参与 GCP 增殖的生理调节。大麻素在 GCPs 中的促增殖作用是通过 CB(1)/AKT/糖原合酶激酶-3β/β-连环蛋白途径介导的。该途径也存在于脑室下区神经元前体细胞的培养物中,表明该途径可能是内源性大麻素调节神经元前体细胞增殖的一般机制。这些观察结果表明,内源性大麻素构成了一类新的脂质信号分子,它们可能在大脑发育过程中对神经元前体细胞增殖产生广泛影响。